ArticleNPJ genomic medicine2021

Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.

Zicheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.